SCHEMBL19985673

SCHEMBL19985673

CCCCCCc1ccc(Nc2ccc(CCCC)cc2)cc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 3/20 0.56
TP53 P04637 2/20 0.56
CYP3A4 P08684 2/20 0.56
MEN1 O00255 2/20 0.56
MAPT P10636 2/20 0.56
KMT2A Q03164 2/20 0.56
ALOX5 P09917 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
HTT P42858 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
ESR1 P03372 2/20 0.50
ADRA2A P08913 2/20 0.50
ADORA3 P0DMS8 2/20 0.50
TACR2 P21452 2/20 0.50
SLC6A2 P23975 2/20 0.50
SLC6A4 P31645 2/20 0.50
SLC6A3 Q01959 2/20 0.50
ALDH1A1 P00352 2/20 0.50
LMNA P02545 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19986528 0.87 TYR (0.58) TYRTP53CYP3A4MEN1MAPT
SCHEMBL19987276 0.87 TYR (0.58) TYRTP53CYP3A4MEN1MAPT
SCHEMBL11248095 0.83 TYR (0.69) TYRTP53CYP3A4MEN1MAPT
SCHEMBL28793656 0.83 TYR (0.69) TYRTP53CYP3A4MEN1MAPT
SCHEMBL258169 0.83 ESR1 (0.59) TP53CYP3A4MEN1MAPTKMT2A
SCHEMBL19979476 0.82 UNG (0.49) TP53CYP3A4ESR1ADRA2AADORA3
SCHEMBL4959142 0.81 TYR (0.71) TYRTP53CYP3A4MEN1MAPT
SCHEMBL9651371 0.81 TYR (0.71) TYRTP53CYP3A4MEN1MAPT
SCHEMBL4958674 0.81 TYR (0.71) TYRTP53CYP3A4MEN1MAPT
SCHEMBL4961630 0.81 TYR (0.71) TYRTP53CYP3A4MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180079987-A1 LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS LANXESS SOLUTIONS US INC. 2018-03-22 US disclosed
US-20180079985-A1 ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS LANXESS SOLUTIONS US INC. 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180079985-A1 ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS GPX4, GSTO1, LPO TYR 11/4885TP53 1344/4885CYP3A4 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.